Why Your Biotech Partner's 'Rush Mode' Should Be a Core Capability, Not an Emergency Button
An industry insider argues that the ability to handle true rush orders is a fundamental test of a CDMO's operational maturity, using real-world examples from pharmaceutical and biotech manufacturing.
Read more